Apexbio Technology LLC_公司信息_产品

英文名称	CAS号	中文名	中文别名	分子式	分子量	EINECS号
Raltegravir Potassium	871038-72-1	雷特格韦钾盐	ISENTRESS POTASSIUM SALT;MK0518 POTASSIUM SALT;MK-0518 POTASSIUM SALT;MK 0518 POTASSIUM SALT;雷特格韦钾盐;拉替拉韦钾;N-(2-(4-(4-氟苄基氨基甲酰基)-5-羟基-1-甲基-6-氧代-1,6-二氢嘧啶-2-基)丙-2-基)-5-甲基-1,3,4-恶二唑-2-甲酰胺钾盐(拉替拉韦中间体);拉替拉韦钾(雷特格韦钾盐);N-(2-(4-(4-氟苄基氨基甲酰基)-5-羟基-1-甲基-6-氧代-1,4-恶二唑-3-	C20H20FKN6O5	482.51	682-461-3
Pyronaridine Tetraphosphate	76748-86-2	4-[(7-氯-2-甲氧基-1,5-二氢吡啶并[3,2-b]喹啉-10-基)亚氨]-2,6-二(吡咯烷-1-基甲基)环己-2,5-二烯-1-酮磷酸盐 (1:4)	4-[(7-氯-2-甲氧基-1,5-二氢吡啶并[3,2-b]喹啉-10-基)亚氨]-2,6-二(吡咯烷-1-基甲基)环己-2,5-二烯-1-酮磷酸盐 (1:4)	C29H44ClN5O18P4	910.03
(2'R)-2'-Deoxy-2'-fluoro-2'-methyl-uridine	863329-66-2	(2'R)-2'-脱氧-2'-氟-2'-甲基脲苷	索非布韦IMP-11;(2'R)-2'-脱氧-2'-氟-2'-甲基脲苷;2'-脱氧-2'-氟-2'-甲基脲苷;索氟布韦中间体 SF-1;索非布韦中间体;索非布韦中间体3;(2'R)-2'-脱氧-2'-氟-2'-甲基脲苷(索非布韦中间体);(2'R)-2'-脱氧-2'-氟-2'-	C10H13FN2O5	260.219023	810-481-6
SB939	929016-96-6	(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羟基丙烯酰胺	PRACINOSTAT (SB939)>98%;CS-60;(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羟基丙烯酰胺;(E)-3-(2-BUTYL-1-(2-(DIETHYLAMINO)ETHYL)-1H-BENZO[D]IMIDAZOL-5-YL)-N-HYDROXYACRYLAMIDE;(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羟基丙烯酰胺 (SB 939);PRACINOSTAT (SB939);SB939;SB-939;SB939;SB-939;SB 939	C20H30N4O2	358.4778
Pioglitazone hydrochloride	112529-15-4	吡格列酮	盐酸吡格列酮,安可妥;匹格列酮盐酸盐(标准品);PIOGLITAZONE HCL 盐酸吡格列酮;PIOGLITAZONE HYDROCHLORIDE 盐酸吡格列酮;盐酸吡格列酮溶液,100PPM;5-{4-[2-(5-乙基-2-吡啶)-乙氧基]-苯基}-2,4-噻唑烷二酮盐酸盐 25G;5-{4-[2-(5-乙基-2-吡啶)-乙氧基]-苯基}-2,4-噻唑烷二酮盐酸盐;盐酸吡格列酮;盐酸吡格列酮	C19H20N2O3S.HCL	392.9
pimobendan	74150-27-9	匹莫苯丹	匹莫苯旦;匹莫苯丹 1G;匹莫苯,匹莫苯丹;VETMEDIN;ACARDI;PIMOBENDANE;心血管系统用药-匹莫苯丹;匹莫苯;匹莫苯丹;6-[2-(4-甲氧基苯基)-1H-苯并咪唑-5-基]-5-甲基-4,5-二氢-3(2H)-哒嗪酮;4,5-二氢-5-甲基-6-[2-(4-甲氧基苯基)-1H-苯并咪唑-5-基]-3(3H)一哒嗪酮	C19H18N4O2	334.37	640-420-7
PFI-1 (PF-6405761)	1403764-72-6	PFI-1 (PF-6405761)	2-甲氧基-N-(3-甲基-2-氧代-1,2,3,4-四氢喹唑啉-6-基)苯磺酰胺;PFI-1;PFI-1;PFI 1;PFI1;CS-709;PFI 1;PFI1	C16H17N3O4S	347.4
PF-2545920	1292799-56-4	2-[[4-[1-(甲基-11C)-4-(4-吡啶基)-1H-吡唑-3-基]苯氧基]甲基]喹啉	CS-114;2-[[4-[1-(甲基-11C)-4-(4-吡啶基)-1H-吡唑-3-基]苯氧基]甲基]喹啉	C25H20N4O	392.4525
PF-03814735	942487-16-3	N-[2-[(1S,4R)-6-[[4-(环丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氢萘-1,4-亚氨-9-基]-2-氧代乙基]乙酰胺	N-[2-[(1S,4R)-6-[[4-(环丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氢萘-1,4-亚氨-9-基]-2-氧代乙基]乙酰胺;CS-240	C23H25F3N6O2	474.4788096	-0
PD 0325901	391210-10-9	N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺	PD 0325901; PD325901; PD-0325901;(R)-N-(2,3-二羟基丙氧基)-3,4-二氟-2-((2-氟-4-碘苯基)氨基)苯甲酰胺;"PD 0325901 N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺;N-[(2R)-2,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺	C16H14F3IN2O4	482.191	687-152-7
PCI-32765	936563-96-1	依鲁替尼	依鲁替尼;伊布鲁蒂尼杂质;(R)-1-(3-(4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基)哌啶-1-基)丙-2-烯-1-酮;伊鲁替尼;伊布鲁替尼;依鲁替尼;伊布替尼;CS-188;依布鲁替尼	C25H24N6O2	440.5	805-642-2
PCI-24781	783355-60-2	PCI-24781;CRA-02478	PCI-24781;CRA-02478;3-[(二甲基氨基)甲基]-N-[2-[4-[(羟基氨基)羰基]苯氧基]乙基]-2-苯并呋喃甲酰胺;3-[(二甲基氨基)甲基]-N-[2-[4-[(羟基氨基)羰基]苯氧基]乙基]-2-苯并呋喃羧酰胺;阿贝司他;PCI-24781 (ABEXINOSTAT);PCI 24781;CRA 024781;CRA 24781;PCI 24781;ABEXINOSTAT;CRA 024781;CRA 24781;ABEXINOSTAT	C21H23N3O5	397.42442	811-183-9
panobinostat	404950-80-7	帕比司他	2-丙烯酰胺,N-羟基-3-[4-[[[2-(2-甲基-1H-吲哚-3-基)乙基]氨基]甲基]苯基]-,(3E)-	C21H23N3O2	349.42622
Olmesartan medoxomil	144689-63-4	奥美沙坦酯	2,3-二羟基-2-丁烯基-4-(1-羟基-1-甲基乙基)-2-丙基-1-[4-(2-1H-四唑-5-苯基)苄基]咪唑-5-羧酸酯环-2,3-碳酸酯;奥美沙坦酯;奥美沙坦酯(标准品);奥美沙坦酯/2,3-碳酸酯;野生地榆提取物	C29H30N6O6	558.585
Olaparib	763113-22-0	奥拉帕尼	AZD2281;KU-0059436;KU0059436;AZD-2281;KU0059436;AZD 2281;奥拉帕利杂质;4-[4-氟-3-(哌嗪-1-环丙基羰基)苄基]-2H-酞嗪-1-酮;奥拉帕尼,PARP 抑制剂;4-[3-[4-(环丙烷羰基)哌嗪-1-羰基]-4-氟苄基]酞嗪-1(2H)-酮;奥拉帕尼AZD2281,KU-0059436;1-(环丙基羰基)-4-[5-[(3,4-二氢-4-氧代-1-酞嗪)甲基]-3-氟苯甲酰]哌嗪	C24H23FN4O3	434.469	642-941-5
NVP-BEP800	847559-80-2	NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE	NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE;CS-1973;VER-82576;NVP BEP800;VER82576;NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE;2-氨基-4-[2,4-二氯-5-[2-(1-吡咯烷基)乙氧基]苯基]-N-乙基噻吩并[2,3-D]嘧啶-6-甲酰胺;VER-82576 (NVP-BEP800)	C21H23Cl2N5O2S	480.42
Nutlin-3	890090-75-2	4-[[4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮	CS-1927;4-[[4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮;NUTLIN 3 500MG	C30H30Cl2N4O4	581.49
NSC-207895 (XI-006)	58131-57-0	4-(4-甲基-1-哌嗪基)-7-硝基-2,1,3-苯并二唑 3-氧化物	4-(4-甲基-1-哌嗪基)-7-硝基-2,1,3-苯并二唑 3-氧化物	C11H13N5O4	279.25202	200-258-5
NLG919	1402836-58-1	1-CYCLOHEXYL-2-(5H-IMIDAZO[5,1-A]ISOINDOL-5-YL)ETHANOL	1-环己基-2-(5H-咪唑并[5,1-a]异吲哚-5-基)乙醇;NLG-919;NLG 919;IDO INHIBITOR;GDC-0919;GDC 0919;GDC0919;CS-820;1-CYCLOHEXYL-2-(5H-IMIDAZO[5,1-A]ISOINDOL-5-YL)ETHANOL;ALPHA-环己基-5H-咪唑并[5,1-A]异吲哚-5-乙醇;1-环己基-2-(5H-咪唑并[5,1-A]异吲哚-5-基)乙醇;5-(2-环己基-2-羟基乙基)-5H-咪唑并[5,1-A]异吲哚;NLG919;NLG-919	C18H22N2O	282.39	1592732-453-0
Nepicastat hydrochloride	170151-24-3	NEPICASTAT HYDROCHLORIDE	NEPICASTAT HYDROCHLORIDE;内匹司他盐酸盐;SYN-117 HYDROCHLORIDE;RS-25560-197 HYDROCHLORIDE;(S)-5-(氨基甲基)-1-(5,7-二氟-1,2,3,4-四氢萘-2-基)-1H-咪唑-2(3H)-硫酮盐酸盐;盐酸内匹司他	C14H16ClF2N3S	331.812

英文名称

CAS号

中文名

中文别名

分子式

分子量

EINECS号

Raltegravir Potassium

871038-72-1

雷特格韦钾盐

ISENTRESS POTASSIUM SALT;MK0518 POTASSIUM SALT;MK-0518 POTASSIUM SALT;MK 0518 POTASSIUM SALT;雷特格韦钾盐;拉替拉韦钾;N-(2-(4-(4-氟苄基氨基甲酰基)-5-羟基-1-甲基-6-氧代-1,6-二氢嘧啶-2-基)丙-2-基)-5-甲基-1,3,4-恶二唑-2-甲酰胺钾盐(拉替拉韦中间体);拉替拉韦钾(雷特格韦钾盐);N-(2-(4-(4-氟苄基氨基甲酰基)-5-羟基-1-甲基-6-氧代-1,4-恶二唑-3-

C20H20FKN6O5

482.51

682-461-3

Pyronaridine Tetraphosphate

76748-86-2

4-[(7-氯-2-甲氧基-1,5-二氢吡啶并[3,2-b]喹啉-10-基)亚氨]-2,6-二(吡咯烷-1-基甲基)环己-2,5-二烯-1-酮磷酸盐 (1:4)

C29H44ClN5O18P4

910.03

(2'R)-2'-Deoxy-2'-fluoro-2'-methyl-uridine

863329-66-2

(2'R)-2'-脱氧-2'-氟-2'-甲基脲苷

索非布韦IMP-11;(2'R)-2'-脱氧-2'-氟-2'-甲基脲苷;2'-脱氧-2'-氟-2'-甲基脲苷;索氟布韦中间体 SF-1;索非布韦中间体;索非布韦中间体3;(2'R)-2'-脱氧-2'-氟-2'-甲基脲苷(索非布韦中间体);(2'R)-2'-脱氧-2'-氟-2'-

C10H13FN2O5

260.219023

810-481-6

SB939

929016-96-6

(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羟基丙烯酰胺

PRACINOSTAT (SB939)>98%;CS-60;(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羟基丙烯酰胺;(E)-3-(2-BUTYL-1-(2-(DIETHYLAMINO)ETHYL)-1H-BENZO[D]IMIDAZOL-5-YL)-N-HYDROXYACRYLAMIDE;(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羟基丙烯酰胺 (SB 939);PRACINOSTAT (SB939);SB939;SB-939;SB939;SB-939;SB 939

C20H30N4O2

358.4778

Pioglitazone hydrochloride

112529-15-4

吡格列酮

盐酸吡格列酮,安可妥;匹格列酮盐酸盐(标准品);PIOGLITAZONE HCL 盐酸吡格列酮;PIOGLITAZONE HYDROCHLORIDE 盐酸吡格列酮;盐酸吡格列酮溶液,100PPM;5-{4-[2-(5-乙基-2-吡啶)-乙氧基]-苯基}-2,4-噻唑烷二酮盐酸盐 25G;5-{4-[2-(5-乙基-2-吡啶)-乙氧基]-苯基}-2,4-噻唑烷二酮盐酸盐;盐酸吡格列酮;盐酸吡格列酮

C19H20N2O3S.HCL

392.9

pimobendan

74150-27-9

匹莫苯丹

匹莫苯旦;匹莫苯丹 1G;匹莫苯,匹莫苯丹;VETMEDIN;ACARDI;PIMOBENDANE;心血管系统用药-匹莫苯丹;匹莫苯;匹莫苯丹;6-[2-(4-甲氧基苯基)-1H-苯并咪唑-5-基]-5-甲基-4,5-二氢-3(2H)-哒嗪酮;4,5-二氢-5-甲基-6-[2-(4-甲氧基苯基)-1H-苯并咪唑-5-基]-3(3H)一哒嗪酮

C19H18N4O2

334.37

640-420-7

PFI-1 (PF-6405761)

1403764-72-6

PFI-1 (PF-6405761)

2-甲氧基-N-(3-甲基-2-氧代-1,2,3,4-四氢喹唑啉-6-基)苯磺酰胺;PFI-1;PFI-1;PFI 1;PFI1;CS-709;PFI 1;PFI1

C16H17N3O4S

347.4

PF-2545920

1292799-56-4

2-[[4-[1-(甲基-11C)-4-(4-吡啶基)-1H-吡唑-3-基]苯氧基]甲基]喹啉

CS-114;2-[[4-[1-(甲基-11C)-4-(4-吡啶基)-1H-吡唑-3-基]苯氧基]甲基]喹啉

C25H20N4O

392.4525

PF-03814735

942487-16-3

N-[2-[(1S,4R)-6-[[4-(环丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氢萘-1,4-亚氨-9-基]-2-氧代乙基]乙酰胺

N-[2-[(1S,4R)-6-[[4-(环丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氢萘-1,4-亚氨-9-基]-2-氧代乙基]乙酰胺;CS-240

C23H25F3N6O2

474.4788096

-0

PD 0325901

391210-10-9

N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺

PD 0325901; PD325901; PD-0325901;(R)-N-(2,3-二羟基丙氧基)-3,4-二氟-2-((2-氟-4-碘苯基)氨基)苯甲酰胺;"PD 0325901 N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺;N-[(2R)-2,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺

C16H14F3IN2O4

482.191

687-152-7

PCI-32765

936563-96-1

依鲁替尼

依鲁替尼;伊布鲁蒂尼杂质;(R)-1-(3-(4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基)哌啶-1-基)丙-2-烯-1-酮;伊鲁替尼;伊布鲁替尼;依鲁替尼;伊布替尼;CS-188;依布鲁替尼

C25H24N6O2

440.5

805-642-2

PCI-24781

783355-60-2

PCI-24781;CRA-02478

PCI-24781;CRA-02478;3-[(二甲基氨基)甲基]-N-[2-[4-[(羟基氨基)羰基]苯氧基]乙基]-2-苯并呋喃甲酰胺;3-[(二甲基氨基)甲基]-N-[2-[4-[(羟基氨基)羰基]苯氧基]乙基]-2-苯并呋喃羧酰胺;阿贝司他;PCI-24781 (ABEXINOSTAT);PCI 24781;CRA 024781;CRA 24781;PCI 24781;ABEXINOSTAT;CRA 024781;CRA 24781;ABEXINOSTAT

C21H23N3O5

397.42442

811-183-9

panobinostat

404950-80-7

帕比司他

2-丙烯酰胺,N-羟基-3-[4-[[[2-(2-甲基-1H-吲哚-3-基)乙基]氨基]甲基]苯基]-,(3E)-

C21H23N3O2

349.42622

Olmesartan medoxomil

144689-63-4

奥美沙坦酯

2,3-二羟基-2-丁烯基-4-(1-羟基-1-甲基乙基)-2-丙基-1-[4-(2-1H-四唑-5-苯基)苄基]咪唑-5-羧酸酯环-2,3-碳酸酯;奥美沙坦酯;奥美沙坦酯(标准品);奥美沙坦酯/2,3-碳酸酯;野生地榆提取物

C29H30N6O6

558.585

Olaparib

763113-22-0

奥拉帕尼

AZD2281;KU-0059436;KU0059436;AZD-2281;KU0059436;AZD 2281;奥拉帕利杂质;4-[4-氟-3-(哌嗪-1-环丙基羰基)苄基]-2H-酞嗪-1-酮;奥拉帕尼,PARP 抑制剂;4-[3-[4-(环丙烷羰基)哌嗪-1-羰基]-4-氟苄基]酞嗪-1(2H)-酮;奥拉帕尼AZD2281,KU-0059436;1-(环丙基羰基)-4-[5-[(3,4-二氢-4-氧代-1-酞嗪)甲基]-3-氟苯甲酰]哌嗪

C24H23FN4O3

434.469

642-941-5

NVP-BEP800

847559-80-2

NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE

NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE;CS-1973;VER-82576;NVP BEP800;VER82576;NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE;2-氨基-4-[2,4-二氯-5-[2-(1-吡咯烷基)乙氧基]苯基]-N-乙基噻吩并[2,3-D]嘧啶-6-甲酰胺;VER-82576 (NVP-BEP800)

C21H23Cl2N5O2S

480.42

Nutlin-3

890090-75-2

4-[[4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮

CS-1927;4-[[4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮;NUTLIN 3 500MG

C30H30Cl2N4O4

581.49

NSC-207895 (XI-006)

58131-57-0

4-(4-甲基-1-哌嗪基)-7-硝基-2,1,3-苯并二唑 3-氧化物

C11H13N5O4

279.25202

200-258-5

NLG919

1402836-58-1

1-CYCLOHEXYL-2-(5H-IMIDAZO[5,1-A]ISOINDOL-5-YL)ETHANOL

1-环己基-2-(5H-咪唑并[5,1-a]异吲哚-5-基)乙醇;NLG-919;NLG 919;IDO INHIBITOR;GDC-0919;GDC 0919;GDC0919;CS-820;1-CYCLOHEXYL-2-(5H-IMIDAZO[5,1-A]ISOINDOL-5-YL)ETHANOL;ALPHA-环己基-5H-咪唑并[5,1-A]异吲哚-5-乙醇;1-环己基-2-(5H-咪唑并[5,1-A]异吲哚-5-基)乙醇;5-(2-环己基-2-羟基乙基)-5H-咪唑并[5,1-A]异吲哚;NLG919;NLG-919

C18H22N2O

282.39

1592732-453-0

Nepicastat hydrochloride

170151-24-3

NEPICASTAT HYDROCHLORIDE

NEPICASTAT HYDROCHLORIDE;内匹司他盐酸盐;SYN-117 HYDROCHLORIDE;RS-25560-197 HYDROCHLORIDE;(S)-5-(氨基甲基)-1-(5,7-二氟-1,2,3,4-四氢萘-2-基)-1H-咪唑-2(3H)-硫酮盐酸盐;盐酸内匹司他

C14H16ClF2N3S

331.812